Section 4: Contrast-induced AKI

Slides:

Advertisements

Similar presentations

REMEDIAL II Renal Insufficiency Following Contrast Media Administration Trial II (REMEDIAL II): RenalGuard™ System In High-Risk Patients for Contrast-Induced.

Advertisements

Renal registry in Hong Kong—the first 20 years Chi Bon Leung, Wai Lun Cheung, Philip Kam Tao Li Kidney International Supplements Volume 5, Issue 1, Pages.

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

Date of download: 6/28/2016 From: Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death Ann Intern Med.

Date of download: 9/17/2016 From: Topical Treatment of Pressure Ulcers with Nerve Growth Factor: A Randomized Clinical Trial Ann Intern Med. 2003;139(8):

From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis Ann Intern Med. 2012;157(4):

Volume 62, Issue 6, Pages (December 2002)

Reduced renal function in patients with simple renal cysts

From: Self-Measured Blood Pressure Monitoring in the Management of HypertensionA Systematic Review and Meta-analysis Ann Intern Med. 2013;159(3):

Volume 56, Issue 4, Pages (October 1999)

Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis

Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation Jordi Bover,

Volume 70, Issue 8, Pages (October 2006)

Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional.

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

Section 2: AKI Definition

Summary of Recommendation Statements

C-reactive protein and dialysis access

Kidney transplantation in a low-resource setting: Nigeria experience

Subclinical rejection in renal transplants is associated with low serum mannose-binding lectin levels Meritxell Ibernon, Francesc Moreso, Daniel Serón

C-reactive protein and dialysis access

Section 5: Dialysis Interventions for Treatment of AKI

Burden of chronic kidney disease: North Africa

Section 3: Prevention and Treatment of AKI

Chapter 3: Management of progression and complications of CKD

Is There Any Reason to Stent Atherosclerotic Renal Artery Stenosis?

Chapter 2: Use of iron to treat anemia in CKD

Volume 76, Pages S50-S99 (August 2009)

Chapter 4: Red cell transfusion to treat anemia in CKD

High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury D.P. Gabriel, J.T. Caramori,

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Volume 68, Issue 5, Pages (November 2005)

This Month in AJKD American Journal of Kidney Diseases

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Yousef Rezaei, MD American Journal of Kidney Diseases

Volume 70, Issue 11, Pages (December 2006)

Volume 62, Issue 6, Pages (December 2002)

Renal Replacement Therapy in Acute Kidney Injury

Volume 71, Issue 6, Pages (March 2007)

Volume 67, Pages S48-S51 (January 2005)

Pathophysiology of contrast medium–induced nephropathy

Antiproteinase 3- and antimyeloperoxidase-associated vasculitis

Dennis G. Moledina, MD, Mark A. Perazella, MD

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 73, Issue 5, Pages (March 2008)

Do CIs Give You Confidence?

Methods for guideline development

Reduced renal function in patients with simple renal cysts

Counteracting progression of renal disease: A look into the future

Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials Christof Westenfelder, Florian E. Togel

Contrast medium-induced nephropathy: The pathophysiology

Florian E. Togel, Christof Westenfelder

Neesh Pannu, Braden Manns, Helen Lee, Marcello Tonelli

Trial Quality in Nephrology: How Are We Measuring Up?

Daily nocturnal home hemodialysis

ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial

Carmine Zoccali, Francesca Mallamaci Kidney International

Probiotics for Prevention of Ventilator-Associated Pneumonia

Current status of maintenance hemodialysis in Beijing, China

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Vikas R. Dharnidharka, Michael E. Seifert Kidney International

Section 4: Contrast-induced AKI

Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti

Dana V. Rizk, David G. Warnock Kidney International

Strategies for iron supplementation: Oral versus intravenous

Michael Reed et al. JCIN 2009;2:

Ronen Levi, Justin Silver Kidney International

Presentation transcript:

Section 4: Contrast-induced AKI Kidney International Supplements Volume 2, Issue 1, Pages 69-88 (March 2012) DOI: 10.1038/kisup.2011.34 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 13 Sample questionnaire. Asterisks denote questions with the highest association with abnormal renal function. Adapted from Choyke PL, Cady J, DePollar SL et al. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 1998; 4: 65–69 with permission.411 Kidney International Supplements 2012 2, 69-88DOI: (10.1038/kisup.2011.34) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 14 Risk for contrast-induced nephropathy. (a) Iodixanol vs. iohexol and risk for contrast-induced nephropathy; (b) iodixanol vs. nonionic low-osmolar contrast media other than iohexol and risk for contrast-induced nephropathy. Reprinted from Heinrich MC, Haberle L, Muller V et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009; 250: 68–86 with permission, copyright 2009, from Radiological Society of North America457; accessed http://radiology.rsna.org/content/250/1/68.long Kidney International Supplements 2012 2, 69-88DOI: (10.1038/kisup.2011.34) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 15 Bicarbonate vs. saline and risk of CI-AKI. Reprinted from Zoungas S, Ninomiya T, Huxley R et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009; 151: 631–638 with permission from American College of Physicians481; accessed http://www.annals.org/content/151/9/631.full Kidney International Supplements 2012 2, 69-88DOI: (10.1038/kisup.2011.34) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 16 NAC and bicarbonate vs. NAC for risk of CI-AKI. Reprinted from Brown, JR, Block CA, Malenka DJ et al. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. JACC Cardiovasc Interv 2009; 2: 1116–1124,503 copyright 2009, with permission from American College of Cardiology Foundation; accessed http://interventions.onlinejacc.org/cgi/content/full/2/11/1116 Kidney International Supplements 2012 2, 69-88DOI: (10.1038/kisup.2011.34) Copyright © 2012 International Society of Nephrology Terms and Conditions